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Cooperation between the innate and adaptive immune responses is critical for enabling
protective immunity against various invading microbes. Distinct types of effector T cells
have different functions in adaptive immune responses. Th1 cells play important roles in
the control of intracellular bacteria by producing IFN-γ to activate macrophages and in
anti-viral immunity by producing IFN-γ and activating cytotoxic T lymphocytes. Th2 cell-
derived cytokines are important in activating mast cells, eosinophils, and goblet cells in
anti-helminth immunity. Th17 cells are pivotal for the inﬂammatory response mediated
by neutrophils, which resists extracellular bacterial infection. In all cases, it is critical
that the innate immune responses limit the growth and expansion of invading microbes
until antigen-speciﬁc adaptive immune responses are established. Recent studies have
identiﬁed multiple subsets in innate lymphocytes corresponding to previously deﬁned Th
subsets. Classical natural killer cells, RORγ+ lymphoid tissue inducer-related cells, and
Th2-type innate lymphocytes play distinct roles in innate immune responses by producing
Th1, Th17, and Th2 cytokines, respectively. Cooperation between innate lymphocytes and
antigen-speciﬁc T and B cells are likely important in protective immunity against distinct
types of microbes. The most recently identiﬁed subset is the RORγ-independent Lin−Thy-
1+IL-7R+GATA3+ innate lymphocyte subset such as natural helper (NH) cell, which is Id2-
and IL-7-dependent.This population producesTh2 cytokines,most notably IL-5 and IL-13, and
plays a major role in innate immune responses during anti-helminth immunity. In addition,
these cells are likely involved in the pathophysiology of some types of allergic diseases.
We summarize here current knowledge regarding various innate lymphocyte subsets. In
particular, we focus on theTh2-type innate lymphocyte subset.
Keywords: Th2 cytokine, natural helper cell, fat-associated lymphoid cluster, nuocyte, innate helper type 2,
helminth, asthma, allergic inflammation
Innate lymphocytes exhibit various effector functions such as lim-
iting the expansion of microorganisms including viruses, bacteria,
and parasites; unlike T and B cells, innate lymphocytes act with-
out antigen-speciﬁc receptors. In addition to twoprototypic innate
lymphocyte populations,namely classical natural killer (cNK) cells
and lymphoid tissue inducer (LTi) cells, multiple types of innate
lymphocytes have been identiﬁed during the last decade. These
include thymic natural killer (NK) cells, NK receptor-positive LTi
cells,LTi cells producing IL-17 and IL-22 andTh2-type innate lym-
phocytes such as natural helper (NH) cells and nuocytes. The tran-
scription factor Id2 appears to be essential for the differentiation of
all innate lymphocytes, suggesting the presence of a commonprog-
enitor population. Like helper T cell subsets in adaptive immune
responses, NK cells, LTi cells, and Th2-type innate lymphocytes
play distinct roles in innate immune responses by producing Th1,
Th17, and Th2 cytokines, respectively (Figure 1). Cooperation
Abbreviations: CLP, common lymphoid progenitors; FALC, fat-associated lym-
phoid cluster; LMPP, lymphoid-primed multipotent progenitors; LTi, lymphoid
tissue inducer; NH, natural helper; NK, natural killer; TSLP, thymic stromal
lymphopoietin.
between those innate lymphocytes and antigen-speciﬁc T and
B cells is likely important in protective immunity against vari-
ous microbes. Here we review the properties of various innate
lymphocytes and their effector functions.
CONVENTIONAL NK CELLS
CD3−NKp46+ NK cells comprise one of the classical innate lym-
phocyte populations (Walzer et al., 2007). However, recent studies
have revealed that these cells contain both CD127+ (IL-7Rα)
and CD127− cells (Satoh-Takayama et al., 2008; Luci et al., 2009;
Sanos et al., 2009; Table 1). CD127−NKp46+ cells are cNK cells,
which produce interferon-γ (IFN-γ) and exhibit strong cytotox-
icity (Trinchieri, 1989). cNK cells differentiate from lymphoid
progenitor cells and the development of cNK cells requires the
transcription factor E4BP4/NF-IL-3 (Gascoyne et al., 2009; Kami-
zono et al., 2009) and the cytokine IL-15 (Kennedy et al., 2000;
Cooper et al., 2001; Ranson et al., 2003; Vosshenrich et al., 2005).
cNK cells play an important role in innate immune responses
against viral infection, and are particularly important in ﬁghting
herpes virus infections. cNK cells limit the propagation of viruses
prior to the onset of adaptive immune responses associated with
www.frontiersin.org May 2012 | Volume 3 | Article 101 | 1
Koyasu and Moro Innate lymphocytes
the expansion of virus-speciﬁc CD8+ cytotoxic T lymphocytes
(Biron et al., 1999; Arase and Lanier, 2004). cNK cells recognize
ligands that are induced on target cells by viral infection or cel-
lular stresses using speciﬁc receptors such as CD94/NKG2D and
exhibit cytotoxic activity via a variety of effector molecules such
as perforin, granzyme, Fas-L, and TRAIL (Trinchieri, 1989; Biron
et al., 1999; Arase and Lanier, 2004). NK cells differentiating in the
thymus (thymic NK cells) are unique in that they express CD127
(IL-7Rα) and GATA3 unlike cNK cells. Thymic NK cells produce
IFN-γ and GM-CSF at much higher levels than cNK cells and their
differentiation depends on the cytokine IL-7 and the transcription
factor GATA3 (Vosshenrich et al., 2006; Ribeiro et al., 2010).
FIGURE 1 | Cytokine-producing cells in innate and adaptive immune
systems. Just as for Th1, Th2, andTh17 cells in the adaptive immune
system, NK cells, Th2-type innate lymphocytes and LTi cells play distinct
roles in innate immune responses by producingTh1, Th2, andTh17
cytokines, respectively.
RORγ+ INNATE LYMPHOCYTES
Lymphoid tissue inducer cells were originally deﬁned as
Lin−CD4+CD117(c-Kit)+CD127+CD25(IL-2Rα)+ CD90(Thy-
1)+ cells (Mebius et al., 2001) but it was later shown that CD4− LTi
cells are abundantly observed in newborn mice (Sawa et al., 2010).
LTi cells originate from Lin−CD4−CD117intSca-1+CD127+ lym-
phoid progenitor cells in the fetal liver (Mebius et al., 2001). Their
differentiation is dependent on the transcription factors RORγ
and Id2, and IL-7 regulates their survival and activity (Mebius
et al., 1997; Yokota et al., 1999; Sun et al., 2000; Eberl et al.,
2004; Meier et al., 2007). LTi cells are present in the anlagen of
both lymph nodes and Peyer’s patches (Mebius et al., 1997; Sun
et al., 2000; Eberl et al., 2004; Veiga-Fernandes et al., 2007; van de
Pavert et al., 2009) and induce the formation of lymph nodes and
Peyer’s patches during fetal development (Mebius, 2003). Lymph
nodes and Peyer’s patches are missing in the absence of RORγ
(Kurebayashi et al., 2000; Sun et al., 2000). Adult CD4+ LTi cells
promote the maturation of tertiary lymphoid tissues after birth
and the restoration of secondary lymphoid tissues after viral infec-
tion (Scandella et al., 2008; Tsuji et al., 2008). It is intriguing that
the differentiation of adult, but not fetal. LTi is dependent on
Notch signaling (Possot et al., 2011).
Earlier studies have shown that a population of CD4+LTi cells
generates lytic NK1.1+ cells after cultivation with IL-2 (Mebius
et al., 1997; Yoshida et al., 2001), suggesting that LTi cells are prog-
enitors of NK cells. It was later reported that, in humans, “imma-
ture NK cells” expressing CD127 and RORγ develop into NK
cells (Cupedo et al., 2009; Hughes et al., 2009). However, a recent
report showed that tonsillar Lin−CD117+CD127+ cells maintain
CD117 but do not acquire perforin or granzyme B expression
after cultivation with irradiated PBMC, PHA, and IL-2 (Crellin
et al., 2010a). On the other hand, tonsilar Lin−CD117+CD127−
cells lose CD117 expression and acquire perforin, granzyme B,
and several NK receptors. It is possible that the immature NK
cells described previously (Freud et al., 2006; Cupedo et al., 2009;
Hughes et al., 2009) contained both CD127+ LTi and immature
cNK cells. Recent fate mapping analysis in mouse conﬁrmed that
cNK cells develop independently of LTi cells (Satoh-Takayama
et al., 2010; Vonarbourg et al., 2010). In addition, E4BP4/NFIL3
is required for the differentiation of mouse cNK cells but there
Table 1 | Comparison between NK- and LTi-related cells.
Characteristics Cells
cNK Thymic NK NKR+LTi NKR−LTi
RORγ+ RORγ− Adult Fetal
SURFACE PHENOTYPE
CD3 − − − − − −
NKp46 + + + + − −
CD90 + + + + + +
CD127 − + + + + +
Characteristic transcription factor E4BP4 GATA3 RORγ RORγ RORγ
Cytokines IFNγ IFNγ, GM-CSF IL-17, IL-22 IFNγ, IL-17 IL-17, IL-22 TNFα, LTα, LTβ
Localization All lymphoid tissues Thymus Intestine Intestine All lymphoid tissues Lymph node anlagen
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is currently no report of a deﬁciency of LTi-related cells in the
absence of E4BP4/NFIL3.
Recent studies have shown the presence of Lin−CD127+
RORγ+NKp46+ innate lymphocytes sharing the characteristics of
bothNK and LTi cells (NKR+LTi cells,Table 1). BecauseNKR+LTi
produce IL-22, these cells are sometimes called NK22 (Cella et al.,
2009), NCR22 (Satoh-Takayama et al., 2010), or ILC22 (Spits and
Di Santo, 2011). Although these cells express NKp46, they exhibit
little cytotoxic activity. Most NKR+LTi cells are present in the
intestine while NKR−LTi cells are found in all lymphoid tissues
(Reynders et al., 2011; Table 1). Approximately 90% of NKp46+
cells in the lamina propria of small intestine are NKR+LTi express-
ing CD127 and only 10% are cNK cells, both of which are absent
in Id2−/− mice without affecting T cells (Satoh-Takayama et al.,
2008). CD127−NKp46+ cells are increased in IL-15 transgenic
mice and CD127+NKp46− cells are decreased in IL-7−/− mice
while total NKp46+ cells were unchanged in both cases (Satoh-
Takayama et al., 2008), indicating the dependence of cNK cells on
IL-15 and NKR+LTi cells on IL-7.
NKR+LTi cells are characterized by the expression of RORγ
and IL-22 and their differentiation is dependent on RORγ while
RORγ is not required for the differentiation of cNK cells (Satoh-
Takayama et al., 2008; Luci et al., 2009; Sanos et al., 2009). RORγ
fate mapping analysis using rorc-Cre mice (Lochner et al., 2008),
in which Cre recombinase is inserted into the rorc locus encod-
ing RORγ, that were further crossed with loxP-ﬂanked YFP Rosa26
(Rosa-YFP) mice (Srinivas et al., 2001) revealed that YFP+ cells
that have previously expressed RORγ (herein RORγfm+ cells)
were either LTi cells (NKR−LTi cells) or NKR+LTi cells and no
cNK cells in the bone marrow, spleen, liver, or lymph nodes were
RORγfm+ (Satoh-Takayama et al., 2010; Vonarbourg et al., 2010;
Figure 2). RORγfm+ cells are composed of both NKp46+ and
NKp46− populations and NKp46−RORγfm+ cells are identical to
LTi cells. LTi cells express CD25 and CCR6 but NKR+LTi cells
do not express CD25 or CCR6. NKR+LTi cells are CD4fm+, indi-
cating that these cells are derived from CD4+RORγ+ LTi cells
(Figure 2). Notably, RORγ− NKR+LTi cells produce IFNγ as
cNK cells (Satoh-Takayama et al., 2010; Vonarbourg et al., 2010;
Table 1). RORγ− NKR+LTi cells and thymic NK cells share some
characteristics but their cytokine production proﬁles are different
(Table 1). In the human, the CD3−CD127+NKp44+ cell pop-
ulation expresses RORγ and is a counterpart of the NKR+LTi
population inmouse (Cella et al., 2009; Cupedo et al., 2009; Crellin
et al., 2010a).
Adult LTi cells provide effector functions by producing IL-17
and IL-22 (Cupedo et al., 2009; Takatori et al., 2009). LTi cells pro-
ducing high levels of these cytokines are CD4− and are sometimes
called ILC17 (Spits and Di Santo, 2011). Production of IL-17 and
IL-22 is further enhanced in vitro upon stimulation with IL-23
(Cella et al., 2009; Buonocore et al., 2010). LTi cells also produce
IL-17 and IL-22 in vivo in response to zymosan (Takatori et al.,
2009) or ﬂagellin (Van Maele et al., 2010) but LTi cells do not
directly respond to microbe-derived substances. Other cells such
as dendritic cells and macrophages likely mediate the effects of
zymosan and ﬂagellin.
NKR+LTi cells are mainly present in lamina propria of the
intestinal mucosa and are important in innate immune responses
againstCitrobacter rodentium (Satoh-Takayama et al., 2008; Zheng
et al., 2008; Luci et al., 2009; Sanos et al., 2009). IL-22 is an
important cytokine in the activation and defense of epithelial cells
(Zenewicz et al., 2008;Wolk et al., 2010). Because IL-22 induces the
production of antimicrobial peptides such as β-defensin psoriasin,
calgranulinA,calgranulinB,RegIIIβ, andRegIIIγby epithelial cells
(Wolk et al., 2004, 2006; Zheng et al., 2008), IL-22 is important
for protection against C. rodentium (Zheng et al., 2008; Sonnen-
berg et al., 2011),Klebsiella pneumoniae (Happel et al., 2005; Aujla
FIGURE 2 | Developmental relationships between various
innate lymphocytes. Cytokines and transcription factors involved in
the differentiation of innate lymphocyte subsets are shown. The
plasticity of RORγ+ LTi-related innate lymphocytes is noted as
shown here but the relationship between NH cells and nuocytes is
currently unknown.
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et al., 2008), and Candida albicans (De Luca et al., 2010). Thus,
NKR+LTi cells play a major role in the innate immune responses
against those microbes through the production of IL-22.
Lymphoid tissue inducer-related cells are also involved in the
pathophysiology of some forms of inﬂammatory colitis (Buono-
core et al., 2010; Vonarbourg et al., 2010). Inﬂammatory colitis
induced by administration of anti-CD40 mAb is not induced
in γc−/−rag2−/− mice lacking all innate lymphocytes but adop-
tive transfer of NKR+LTi cells restores the induction of colitis.
Intriguingly, IL-23-responsive IFN-γ-producing innate lympho-
cytes were found in the lamina propria of inﬂammatory bowel
disease patients (Takayama et al., 2010), implying the involvement
of innate lymphocytes in human diseases. Intestinal ﬂora does not
affect the number of LTi cells but affects the function of LTi cells
(Sawa et al., 2011). Expression of IL-22 but not IL-17 is higher
in germ-free mice than in SPF mice and antibiotic treatment in
SPF mice increased the expression of IL-22. IL-22 expression was
higher in il25−/− LTi cells and administration of IL-25 suppressed
IL-22 expression in wild type LTi cells, suggesting that epithelial
cell-derived IL-25 suppressed IL-22 production (Sawa et al., 2011).
The effect of IL-25 is indirect because LTi cells do not express IL-
25 receptors (IL-17RB). It is likely that IL-17RB+ dendritic cells
suppress IL-22 production in a contact-dependent manner.
Th2 CYTOKINE-PRODUCING INNATE LYMPHOCYTES
The third subset of innate lymphocytes identiﬁed most recently
is the RORγ-independent Lin−CD90+CD127+GATA3+ innate
lymphocyte subset, which is Id2- and IL-7-dependent (Figure 2).
This population is capable of producing Th2 cytokines, most
notably IL-5 and IL-13, but not IL-4. This Th2 cytokine-producing
subset was ﬁrst reported in 2010 and named NH cells (Moro et al.,
2010), MPPtype2 (Saenz et al., 2010), nuocytes (Neill et al., 2010),
or innate helper type 2 (Ih2) cells (Price et al., 2010). Among
these reports, NH cells were identiﬁed in naïve animals while all
other cell types were observed upon cytokine administration or
helminth infection in cytokine-GFP reporter mice. Although their
relationships are currently unclear, NH cells, nuocytes, and Ih2
cells share similar characteristics (Table 2). MPPtype2 cells seem to
be of myeloid lineage. It remains to be determined how many cell
types are present in this subset.
Th2 activity is important for anti-helminth immunity (McKen-
zie et al., 1998; Urban et al., 1998; Perrigoue et al., 2008; Maizels
et al., 2009). In addition, Th2 reactions are involved in the patho-
physiology of various allergic diseases including asthma (Grünig
et al., 1998; Walter et al., 2001; Larché et al., 2003; Holgate and
Polosa, 2008). Although the antigen-speciﬁc Th2 response plays
a central role both in protective immunity against helminths and
antigen-speciﬁc allergic responses, accumulating evidence indi-
cates the involvement of innate immune cells in the early phase of
Th2 responses.
Recent studies shed light on the role of epithelial cells in
regulating Th2 responses. Epithelial cell-derived thymic stromal
lymphopoietin (TSLP), IL-25 and IL-33 have been implicated in
regulating Th2-type innate immune responses (Fort et al., 2001;
Soumelis et al., 2002; Schmitz et al., 2005; Zaph et al., 2007). These
cytokines induce Th2-type cytokines from various cells (Min et al.,
2004;Gessner et al., 2005;Voehringer et al., 2006; Saenz et al., 2008;
Table 2 | Comparison betweenTh2-type innate lymphocytes.
Characteristics Cells
NH cell Nuocyte/Ih2 Innate IL-9
producer
MPPtype2
GFP− GFP+
SURFACE PHENOTYPE
CD45 + + +
Sca-1 + + +/− + +
CD90 + +
CD34 − − +/− +/−
CD44 + +
FcεRI − −
IL-17RB + +
CD127 + + − − +/−
ICOS + ++
CD117 + +/− − + +
T1/ST2 + +/− + +/− +/−
CD25 + − +/−
MHC class II − + +/− +* +/−*
LOCALIZATION
FALC + −
Lymph nodes − + + + +
Lung +** +** +**
CYTOKINE RESPONSIVENESS
IL-2 + + +
IL-25 − +*** − +*** +***
IL-2+ IL-25 + +
IL-33 + +/−**** +
IL-7+ IL-33 + +
*After cultivation with IL-3 and SCF.
**Mostly after administration of papain or IL-33, and helminth infection.
***These cells were induced by IL-25 in vivo.
****IL-33 alone induces only moderate proliferation.
Sokol et al., 2008; Terashima et al., 2008). TSLP was originally
identiﬁed from thymic stromal cells and thought to support the
growth and differentiation of T and B cells but is now considered
to be a Th2-inducing cytokine (Eisenbarth et al., 2002). TSLP acts
to induce dendritic cells capable of differentiating naïve CD4+ T
cells to Th2 cells (Soumelis et al., 2002; Ying et al., 2005). IL-33
induces the production of Th2-type cytokines from mast cells (Ho
et al., 2007), basophils (Kondo et al., 2008), eosinophils (Perrigoue
et al., 2009), CD4+ T cells (Louten et al., 2011), CD8+ T cells
(Yang et al., 2011a), Tregs (Brunner et al., 2011), and CD11b+
innate cells (Turnquist et al., 2011). IL-25 activates NKT cells
(Terashima et al., 2008) and CD117+ non-T, non-B cells (Fal-
lon et al., 2006; Perrigoue et al., 2009) and induces proallergic
type 2 responses (Angkasekwinai et al., 2007). Administration of
IL-25 and IL-33 induces rapid production of Th2-type cytokines
such as IL-5 and IL-13 in mice independently of T or B cells (Fort
et al., 2001; Hurst et al., 2002; Humphreys et al., 2008), suggesting
that Th2 cytokine-producing innate lymphocytes, i.e., Th2-type
innate lymphocytes, are regulated by those epithelial cell-derived
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cytokines. CD117+ non-T,non-B cellswere not induced in il25−/−
mice upon helminth infection (Fallon et al., 2006), indicating that
these cells do not responds to IL-33.
Natural helper cells were discovered in adipose tissues and are
present in lymphoid clusters termed fat-associated lymphoid clus-
ters or FALC (Moro et al., 2010). In addition to CD90 and CD127,
NH cells isolated from FALC express CD117, Sca-1, CD25, CD44,
CD45, CD69, α4β7, ICOS, IL-17RB (IL-25R), and T1/ST2 (IL-
33R)but lackMHCclass II,Flt3,and conventional lineagemarkers.
NH cells were also observed in the bone marrow (Brickshawana
et al., 2011 and our unpublished observation) although the expres-
sion level of CD117 is very low in the bone marrow. NH cells were
also observed in the lung of naïve mice although the numbers are
small (Monticelli et al., 2011; Halim et al., 2012; Ikutani et al.,
2012). IL-7 supports the survival of NH cells and IL-2 induces
their proliferation (Moro et al., 2010). Neither FALC NH cells nor
lung NH cells differentiate under myeloid differentiation condi-
tions. NH cells do not differentiate to T cells upon culture on OP1
stromal cells expressing delta-like 1 or upon intrathymic transfer
(Moro et al., 2010; Yang et al., 2011b).
In terms of transcription factors involved in the differentia-
tion of lymphocytes, NH cells express Id2 and GATA3 but lack
RORγ. FALC and NH cells are present in rorc (RORγ)-deﬁcient
mice, indicating that LTi are not involved in FALC formation or
in the differentiation of NH cells. Notable characteristics of NH
cells are their abilities to constitutively produce IL-5, IL-6, and
IL-13 and to support IgA production from B cells in vitro as well
as self-renewal of B1 cells in vitro and in vivo (Figure 3A). Upon
activation with IL-33,NH cells produce large amounts of IL-5 and
IL-13 (Figure 3B) and the amounts produced by 5,000 cells for
5 days reach microgram quantities. IL-25 alone does not activate
NH cells but a combination of IL-2 plus IL-25 activates NH cells to
produce IL-5 and IL-13. It should be noted that NH cells express
mRNA for IL-4 but IL-4 protein is induced only by a combina-
tion of phorbol 12-myristate 13-acetate and ionomycin and not by
IL-33 or IL-2+ IL-25. Intranasal administration of IL-33 induces
NH cells in the lung and bronchoalveolar lavage ﬂuid associated
with eosinophilia and IL-25 was much less potent in inducing NH
cells than IL-33 (Wilhelm et al., 2011; Bartemes et al., 2012; and
our unpublished observations).
Natural helper cells play an important role in the innate
immune response against helminth infection (Koyasu et al., 2010).
Nippostrongylus brasiliensis is a model for the migratory pathway
of the human hookworm, which infects subcutaneously, enters
vasculature,migrates to the lungs,molts,penetrates the alveoli, and
ascends the trachea, where the worms are swallowed to complete
maturation in the small intestine (Hotez et al., 2004). Adult worms
are cleared after 8–10 days by a Th2 response (Urban et al., 1998).
Among Th2 cytokines, IL-13 is critical for goblet cell hyperplasia,
which is important for anti-helminth Th2 immunity (Urban et al.,
1998; Mohrs et al., 2005). il4−/− mice show lower Th2 response
but are able to expel the worms (Kopf et al., 1993) but il13−/−
mice are impaired in goblet cell hyperplasia and are unable to
expel the worms (Urban et al., 1998; McKenzie et al., 1999). IL-13,
in addition to IL-5, is important in inducing eosinophilia (Wynn,
2003). Mice deﬁcient for both γc and rag-2 lack NH cells in addi-
tion to T, B, and NK cells. γc−/−rag-2−/− mice produce neither
IL-5 nor IL-13 and are impaired in goblet cell hyperplasia upon N.
brasiliensis infection. Administration of IL-33 fails to induce IL-5
and IL-13 production in γc−/−rag-2−/− mice. Adoptive transfer
of NH cells isolated from FALC restored goblet cell hyperplasia
along with the production of IL-5 and IL-13 (Moro et al., 2010).
NH cells likely contribute to the early production of IL-5 and IL-
13 upon N. brasiliensis infection, which induces eosinophilia and
goblet cell hyperplasia (Figure 3B).
Natural helper cells are present in rag2−/− and nu/nu mice but
absent in id2−/−, γc−/−, il7−/−, and cd127−/− mice (Moro et al.,
2010; Yang et al., 2011b). As expected, NH cells are derived from
common lymphoid progenitors (CLPs) and lymphoid-primed
multipotent progenitors (LMPP), the latter of which retain some
FIGURE 3 | Functions of NH cells. (A) IL-5 and IL-6 constitutively produced by
NH cells support IgA production by B cells. IL-5 supports the growth of B1
cells in the peritoneal cavity. (B) Upon helminth infection, IL-33 produced by
epithelial cells, endothelial cells, and/or adipocytes induces high levels of IL-5
and IL-13 by NH cells, resulting in eosinophilia and goblet cell hyperplasia,
which play important roles in an early phase of anti-helminth immune
responses. Similarly, a combination of IL-2 and IL-25 (IL-2+ IL-25) also induces
large amounts of IL-5 and IL-13 from NH cells.
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myeloid potential (Igarashi et al., 2002; Welner et al., 2009). In
rag1-cre mice crossed with Rosa-YFP mice, more than half of NH
cells are Rag1fm+ (Yang et al., 2011b), indicating the close relation-
ship between NH cells and T/B lymphocytes. Cell transfer analysis
showed that NH cells were generated from hematopoietic stem
cells, LMPPs, and CLPs (Yang et al., 2011b). LMPPs were more
efﬁcient at generating NH cells than CLPs, which is similar to the
case of T cells (Schwarz et al., 2007; Serwold et al., 2009). Lym-
phoid progenitor-derived NH cells express a high level of GATA3
as expected. Again, they expressed il4 mRNA but no IL-4 protein
was detected.
Neill et al. (2010) generated il13-eGFP reporter mice and
demonstrated that administration of IL-25 or IL-33 induced a
GFP+ population in the mesenteric lymph nodes (∼3% of total
cells in mesenteric lymph nodes), ∼80% of which were cells of
unknown lineage. Only a small number of GFP+ cells were present
in the spleen, mesenteric lymph nodes, and bone marrow of naïve
mice (<0.2%) but administration of IL-25 or IL-33 signiﬁcantly
increased the number of GFP+ cells in these organswith the excep-
tion of bone marrow. GFP+ cells were named nuocytes as the
13th letter of the Greek alphabet is nu. IL-25-elicited nuocytes
are present in the mesenteric lymph nodes, intestinal lamina pro-
pria, and spleen and express CD117, Sca-1, CD43, CD45, CD132,
CD127, β7, CD90, ICOS, MHC class II, CD44, CD49d, ICAM-
1, IL-17RB, T1/ST2, and CCR9. Nuocytes express MHC class II
but not CD25, which is different from naïve NH cells that express
CD25 but not MHC class II (Table 2; Moro et al., 2010; Neill et al.,
2010). IL-33-elicited GFP+ cells were also observed in mesenteric
lymph nodes, spleen, and intestinal lamina propria. The authors
then considered CD3−CD19−FcεRI−CD11b−IL-17RB+ cells to
be nuocytes and reported that induction of nuocytes was unaf-
fected in rag2−/−,Wsh/sh, jα18−/−, and rorc−/− mice but impaired
in roar−/− mice (Neill et al., 2010; Wong et al., 2012). In vitro cul-
ture of 106/ml nuocytes prepared from spleens of IL-25-treated
wild type mice produced microgram levels of IL-5 and IL-13 in
response to IL-7+ IL-33 (Neill et al., 2010). Unlike NH cells, nuo-
cytes are reported to produce IL-4 (Wong et al., 2012). In contrast
to nuocytes, NH cells are not found in lymph nodes and, in fact,
do not express the chemokine receptors necessary for lymphocyte
recruitment to the lymph node even with activation (our unpub-
lished observations), which further discriminates NH cells from
nuocytes. Because NH cells produce a large amount of IL-13 in
response to IL-33, it is likely that IL-33-elicited GFP+ cells contain
both NH cells and nuocytes while the majority of IL-25-elicited
GFP+ cells are nuocytes.
Nippostrongylus brasiliensis infection also induced GFP+ cells
in the intestinal lamina propria of il13-eGFP reporter mice (Neill
et al., 2010). il17rb−/− mice expelled N. brasiliensis more slowly
than wild type mice and worm expulsion was severely impaired
in il17rb−/−il1rl1−/− mice lacking both IL-17RB and T1/ST2.
The lack of either IL-17RB or T1/ST2 in il13-eGFP reporter
mice greatly reduced the appearance of GFP+ cells in mesen-
teric lymph nodes. il17rb−/− mice exhibited impaired IL-25-
triggered eosinophilia in the peritoneal cavity and impaired goblet
cell hyperplasia in the intestine. Lin−CD45+ICOS+ cells sorted
from splenocytes of IL-25-treated wild type mice were deﬁned
as nuocytes and adoptive transfer of such nuocytes restored both
eosinophilia and goblet cell hyperplasia.Wormexpulsion is depen-
dent on T cells and rag2−/− mice cannot expel worms even after
transfer of wild type nuocytes. Nuocyte numbers in mesenteric
lymph nodes increased in rag2−/− mice on day 4 after infection of
rag2−/− mice but rapidly decreased on day 6, suggesting that the
expansion of nuocytes is T and/or B cell-dependent.
Intriguingly, two groups (Price et al., 2010; Saenz et al., 2010)
have reported the induction of different types of GFP+ cells in
the same il4-eGFP reporter mice (4-get mice; Mohrs et al., 2001)
upon IL-25 or IL-33 administration. Saenz et al. (2010) observed
that administration of IL-25 to 4-get mice increased a CD117+
non-T, non-B population ∼60-fold in mesenteric lymph nodes
and that this was associated with the increase of il4, il5, and il13
mRNAs in the large intestine (Saenz et al., 2010). GFP+ cells in
the Peyer’s patches and mesenteric lymph nodes were CD117int
compared to mast cells and were present inWsh/sh mice. Intraperi-
toneal administration of IL-25 did not induce GFP+ cells in the
spleen or bone marrow or increase the frequency of NH cells in the
mesentery (Saenz et al., 2010). The CD117int population did not
express gata3, junb, c-maf, stat6, or t1/st2 mRNAs. N. brasilien-
sis infection also induced a CD117int population in mesenteric
lymph nodes in an IL-17RA- and IL-17RB-dependent manner.
Administration of anti-IL-25 antibodies reduced the number
of cells in the CD117int population after N. brasiliensis infec-
tion. The CD117int population contains both GFP+ and GFP−
cells; GFP+ cells were Lin−T1/ST2lo/−CD127lo/− and GFP− cells
were Lin−T1/ST2lo/−CD127−, indicating that there are at least
two CD117int populations induced by IL-25 and N. brasiliensis
infection.
il25−/− mice produced only low levels of Th2-type cytokines
and parasite-speciﬁc IgG1 upon Trichuris muris infection and
were susceptible to T. muris infection. Adoptive transfer of IL-
25-elicited wild type CD117int cells restored the immune response
and protective immunity against T. muris in il25−/− mice, indi-
cating a role for this population in anti-helminth immunity. In
an in vitro culture system, GFP+ cells gave rise to mast cells in the
presence of SCF and IL-3. GFP− cells became mast cells, basophils,
and macrophages in the presence of SCF and IL-3 with or with-
out OP9 stromal cells. Because of such myeloid potential, it is
unlikely that these cells were of lymphoid lineage and thus were
named MPPtype2 for multipotent progenitor cell type 2 (Saenz
et al., 2010). Such myeloid differentiation potential and the lack of
gata3 expression discriminate MPPtype2 from NH cells.
Price et al. (2010) reported that the 4-get mouse has
Lin−CD117loCD90+GFP+ cells inmultiple tissues including liver,
mesenteric lymph nodes, spleen, and bone marrow. This popula-
tion, named Ih2 cells, was present in rag2−/−, Wsh/sh, Δdblgata
mice but absent in γc−/− mice. Ih2 cells seem closer to nuocytes
than to NH cells because Ih2 cells and nuocytes are present in
lymphnodes,while, asmentioned above,NHcellswere not present
in lymph nodes. Mice in which YFP-Cre was inserted into the il13
coding region (YetCre13 mice) thatwere further crossedwithRosa-
YFP mice have Lin−CD117loIL-13fm+ cells, which were similar to
the GFP+ cells observed in 4-get mice. It is intriguing that GFP+
cells in 4-get mice do not produce IL-4 at the protein level, which
indicates that reporter expression does not always correlate with
the expression of the original gene product.
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Administration of 500 ng of IL-25 or IL-33 for four consecu-
tive days to 4-get mice increased GFP+ cells in mesenteric lymph
nodes, spleen, liver, and peritoneum; this was associated with an
increase in eosinophils. Administration of IL-25 to mice obtained
from YetCre13 mice crossed with Rosa-ﬂox-Stop-diophtheria toxin
α mice and 4-get mice greatly reduced Lin−CD117loGFP+ cells
and eosinophils in mesenteric lymph nodes, spleen, liver, and peri-
toneum. N. brasiliensis infection also increased this population
in mesenteric lymph nodes, spleen, and lung. rag2−/− but not
γc−/−rag2−/− mice were able to clear N. brasiliensis after admin-
istration of IL-25 for four consecutive days. Adoptive transfer of
Lin−CD117loGFP+ cells from YetCre13 mice crossed with 4-get
mice into γc−/−rag2−/− mice did not result in clearance of the
worms but administration IL-25 in addition to the transfer of
Lin−CD117loGFP+ cells resulted in eosinophilia and clearance
of worms. N. brasiliensis infection of YetCre13 mice or another
reportermouse strain inwhichhumanCD4coding sequenceswere
inserted into the il13 locus induced YFP+ or human CD4+ cells,
respectively, in the lung (Liang et al., 2012). Induction of YFP+
cells and eosinophilia were impaired inYetCre13 mice crossed with
gata3ﬂox/ﬂox mice, suggesting that sustained expression of IL-13
requires GATA3 (Liang et al., 2012).
Th2-TYPE INNATE LYMPHOCYTES AND ALLERGIC
INFLAMMATION
Signiﬁcant numbers of NH cells are induced in the lung upon
inﬂuenza A virus infection (Chang et al., 2011; Monticelli et al.,
2011). Inﬂuenza virus infection induces IL-33 in the lung and
causes airway hypersensitivity (Chang et al., 2011; Le Gofﬁc et al.,
2011). il1rl1−/− mice did not exhibit H3N1 inﬂuenza A virus
infection-induced airway hypersensitivity while OVA-induced air-
way hypersensitivity was unaffected (Chang et al., 2011). However,
H3N1 infection as well as intranasal administration of IL-33
induced Lin−CD117+Sca-1+T1/ST2+ NH cells in the lung and
bronchoalveolar lavage ﬂuid and this was also observed in rag2−/−
mice. NH cells puriﬁed as Lin−T1/ST2+ cells from IL-33-treated
mice produced IL-5 and IL-13 but not IL-4, IFN-γ, or IL17A after
cultivation with IL-2, IL-33, or IL-2+ IL-33. il13−/− mice did not
develop airway hypersensitivity or cellular inﬁltration upon H3N1
infection, but both responses were restored by adoptive transfer of
NH cells from rag2−/− but not il13−/− mice. Administration of
anti-CD90 mAb depleted NH cells in the lung and impaired air-
way hypersensitivity upon H3N1 infection (Chang et al., 2011),
indicating that NH cells are responsible for airway hypersensitiv-
ity induced by H3N1 inﬂuenza virus infection. There is a caveat,
however, in that anti-CD90 mAb also depletes NK cells in rag2−/−
mice. In addition, NH cells play a major role in airway hypersen-
sitivity induced by glycolipid antigen (Kim et al., 2012) or papain
(Halim et al., 2012). Similarly, nuocytes were reported to play a
role in airway hypersensitivity induced by intranasal administra-
tion of IL-25 or IL-33 in il4/il13 dual reporter mice (Barlow et al.,
2011).
Monticelli et al. (2011) and Halim et al. (2012) reported the
presence of a small number of NH cells in the lung of naïve wild
type and rag1−/− mice. A mouse has 2–3× 104 lung NH cells
which represent 0.4–1% of total live cells in the lung. Lung NH
cells produced IL-5 and IL-13 when cultured with a combination
of IL-2, IL-7, and IL-33. They producedminimal amounts of IL-17
and IL-22 in response to IL-23, conﬁrming the difference between
Th2-type innate lymphocytes and RORγ+ LTi-related Th17-type
innate lymphocytes (Monticelli et al., 2011). LungNHcells express
Id2 but not RORγ as do FALC NH cells, and id2−/− mice lack lung
NH cells as expected.
Increases in the number of lung NH cells were also observed
upon intranasal infectionwithH1N1 inﬂuenzaA virus (Monticelli
et al., 2011). Depletion of NH cells in the lung by intraperi-
toneal injection of anti-CD90 mAb did not affect viral load
but impaired lung functions such as blood oxygen saturation
level and epithelial integrity.H1N1 infection-induced eosinophilia
in the bronchoalveolar lavage ﬂuid and the eosinophilia was
reduced by anti-CD90 mAb treatment. Adoptive transfer of
Lin−CD25+CD90+T1/ST2+ NH cells isolated from the lung of
CD90.1 (Thy-1.1) wild type mice into CD90.2 (Thy-1.2) con-
genic mice treated with anti-CD90.2 mAb restored the epithelial
responses of the recipient mice. Administration of anti-T1/ST2
mAb reduced NH cell numbers and greatly impaired lung func-
tion upon H1N1 infection. Administration of IL-13 to anti-CD90
mAb-treated mice infected with H1N1 restored goblet cell hyper-
plasia but did not improve lung function or virus-induced mor-
bidity and mortality, suggesting the presence of a factor(s) other
than IL-13 involved in the maintenance of epithelial integrity.
Among the cytokines produced by NH cells, amphiregulin was
identiﬁed as a critical factor (Monticelli et al., 2011). Amphireg-
ulin is involved in the remodeling and repair of epithelial injury
(Dolinay et al., 2006; Enomoto et al., 2009; Fukumoto et al., 2010).
Puriﬁed lung NH cells produce amphiregulin in response to IL-
2+ IL-7, and IL-33 further enhanced amphiregulin production
induced by IL-2+ IL-7. Administration of amphiregulin restored
lung function and epithelial integrity in anti-CD90-treated mice
infected with H1N1 without inducing IL-5 or IL-13 (Monticelli
et al., 2011), indicating that amphiregulin produced by IL-33-
activated NH cells plays a critical role in the process of repairing
epithelial integrity after inﬂuenza virus infection.
PROTEASE-INDUCED ALLERGIC RESPONSES AND IL-9
PRODUCING CELLS
IL-9, another Th2 cytokine, is highly expressed in the lungs of
asthmatic patients (Shimbara et al., 2000; Erpenbeck et al., 2003)
and anti-IL-9 mAb is currently in clinical trial for atopic diseases
(White et al., 2009). In mice, overexpression of IL-9 in the lung
induces an asthma-like phenotype in an IL-13-dependent manner
(Temann et al., 1998, 2002, 2007) and blocking of IL-9 reduces
airway hypersensitivity (Kung et al., 2001; Cheng et al., 2002). IL-9
induces mucous production, goblet cell hyperplasia, and other
features of airway remodeling (Townsend et al., 2000; Kearley
et al., 2011), effects shared by IL-13 via goblet cell hyperplasia
(Wynn, 2003) and IL-5 via eosinophilia (Cho et al., 2004). These
results collectively suggest the presence of an IL-9/IL-13 axis in the
lung. On the other hand, IL-9 may not play a critical role in some
forms of asthmatic diseases because the absence of IL-9 shows lit-
tle effect on antigen-induced pulmonary inﬂammation or airway
hypersensitivity (McMillan et al., 2002).
Papain can cause occupational asthma (Novey et al., 1979)
and has been used in allergic models because it has a strong
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adjuvant activity in the induction of asthma-like symptoms and
airway hypersensitivity (Oboki et al., 2010; Wang et al., 2010).
Halim et al. (2012) demonstrated that NH cells play a critical
role in protease allergen-induced airway inﬂammation. NH cells
induced by papain do not respond to IL-33 alone and require IL-
2 or IL-7 along with IL-33 to produce IL-5 and IL-13 (Halim
et al., 2012). Papain-induced transient production of IL-9 in
the lung (Tan et al., 2010), raising the possible involvement of
an IL-9/IL-13 axis in airway hypersensitivity induced by innate
lymphocytes. To examine the source of IL-9, IL-9 fate mapping
mice were generated by crossing il9-Cre mice and rosa-YFP mice
(Wilhelm et al., 2011). Intranasal challenge with papain induces
Th2-type responses with production of IL-4, IL-5, IL-9, and IL-
13 and the appearance of IL-9fm+ cells in bronchoalveolar lavage
ﬂuid, most of which are Lin−CD45+CD90+ cells. These cells did
not express CD117 or CD127 but expressed heterogeneous lev-
els of Sca-1, CD25, T1/ST2, and MHC class II, implying that
these cells are distinct from NH cells or nuocytes, although it
is possible that papain stimulation changes the surface pheno-
type of these cells. Stimulation with PMA and ionomycin in vitro
induced the production of IL-5 and IL-13 but not IL-4 or IL-
9 by IL-9fm+ cells. Papain-induced Lin−CD90+CD25+IL-9fm+
cells responded to IL-2 but not to IL-25, IL-33, or TSLP to
produce IL-9. In addition, TLR ligands did not induce IL-9 pro-
duction by these cells. Intranasal administration of IL-33 also
induced IL-9fm+ cells, which were similar to those induced by
papain.
Papain-induced IL-9 production in the lung was absent in
γc−/−rag2−/− mice, suggesting that innate lymphocytes are the
source of IL-9. In fact, intratracheal transfer of Lin−CD90+ cells
isolated frompapain-challengedmice intoγc−/−rag2−/− mice fol-
lowed by intranasal challenge with papain restored the production
of IL-5, IL-9, and IL-13 (Wilhelm et al., 2011). Papain-treated
mice produced IL-4, IL-5, IL-6, IL-9, and IL-13 in the lung but
administration of anti-IL-2 mAb reduced only IL-9 production.
Papain-treated rag1−/− miceproduced lower amounts of IL-9 than
wild type mice but produced IL-9 at a level similar to wild type
mice when IL-2 was intranasally administered after papain chal-
lenge. Intranasal administration of IL-2 alone showed no effect.
Papain-induced IL-9 producing cells were mostly Lin−CD90+
cells, which also produce IL-13. These results collectively indicate
that innate lymphocytes cooperate with T and/or B cells and that T
and/or B cell-derived IL-2 plays a positive role in IL-9 production
by innate lymphocytes.
Th2-TYPE INNATE LYMPHOCYTES IN HUMANS
Th2-type innate lymphocytes are also observed in humans. The
presence of innate lymphocytes similar to NH cells has been
reported in human gut, lung, mesentery, and blood (Moro et al.,
2010; Mjösberg et al., 2011; Monticelli et al., 2011). FALC and
Lin−CD117+CD127+ cells were observed in human mesentery
(Moro et al., 2010). Human lung and bronchoalveolar lavage
ﬂuid also have a similar Lin−CD25+CD127+T1/ST2+ popu-
lation (Monticelli et al., 2011). CRTH2 was identiﬁed as a
valuable marker for human NH cells (Mjösberg et al., 2011).
CD45hiCD127+CRTH2+ cells produced IL-13 in response to
IL-2+ IL-25 and IL-2+ IL-33. CD45hiCD127+CRTH2+ cells
expressed a low level of RORγ, which is different from mouse
NH cells. It should be noted that RORγ+ LTi cells are able
to produce IL-5 and IL-13 in addition to IL-22 in response to
TLR2 ligands (Crellin et al., 2010b), implying that NH cells and
LTi-related cells share some characteristics in humans. Periph-
eral blood contains Lin−CD45+CD127+CRTH2+ cells express-
ing CD7, CD161, CD62L, and CD25 but lacking NKp44 and
MHC class II. Lin−CD45+CD127+ cells produce a variety of
cytokines including TNFα, IFN-γ, IL-22 IL-17, IL-13, and IL-
2 but only Lin−CD45+CD127+CRTH2+ cells produce IL-13.
Thus, human LTi and Th2-type innate lymphocytes share similar
characteristics.
Rhinosinusitis patients with nasal polyps have more il5
and il13 mRNAs than those without nasal polyps (Van Bru-
aene et al., 2008). Nasal tissue from the nasal polyps of
patients with chronic rhinosinusitis has an increased number of
Lin−CD45+CD127+CD161+CRTH2+ cells,which donot express
RORγ (Mjösberg et al., 2011). Treatment of lamina propria cells
from ulcerative colitis patients with anti-CD161 reduced IL-5
and IL-13 expression (Fuss et al., 2004) and it was proposed
that the depletion of NKT cells resulted in the reduction of
Th2 cytokines (Fuss et al., 2004). However, it is also possible
that the loss of Lin−CD45+CD127+CRTH2+ cells is the cause
of reduced Th2 cytokine production because these cells also
express CD161.
PERSPECTIVES
In this article we have summarized current knowledge regard-
ing various innate lymphocyte subsets by focusing on the most
recently identiﬁed Th2-type innate lymphocyte subsets. As dis-
cussed here, Th2-type innate lymphocytes seem to comprise more
than one type of cells. There are differences between NH cells
and nuocytes/Ih2 cells in migration to lymph nodes, surface phe-
notypes, and cytokine responsiveness. It is likely that there are at
least twodistinct populationswithinTh2-type innate lymphocytes
but it is also possible that there is plasticity within Th2-type innate
lymphocytes as is true for RORγ+ LTi-related innate lymphocytes.
It should be noted that, in many experiments, cells are detected by
reporter gene expression after treatment of mice with cytokines,
viruses, and papain. There is a caveat that such treatment changes
the naïve stage surface phenotypes of cells and it is critical to ana-
lyze innate lymphocytes in naïve mice and examine the changes in
characteristics after activation.
Innate immune cells of myeloid origin express a variety of
toll-like receptors and lectins that respond to microbe-derived
substances (Kawai and Akira, 2010). In contrast, cNK cells and
RORγ+ LTi-related cells express a limited number of toll-like
receptors (Crellin et al., 2010b). It is intriguing that Th2-type
innate lymphocytes do not respond to toll-like receptor ligands
but respond only to cytokines. It will be of interest to deter-
mine whether Th2-type innate lymphocytes directly respond to
microbe-derived substances.
Distinct types of Th cells are involved in the pathophysiology
of various diseases such as inﬂammatory, allergic, and autoim-
mune diseases. It is likely that innate lymphocytes are involved in
the pathophysiology of various diseases via the production of dis-
tinct sets of cytokines (Figure 1). Th2-type innate lymphocytes are
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likely involved in innate immune responses resulting in the patho-
physiology of allergic diseases such as asthma. It will be of interest
to study how innate lymphocytes are involved in disease onset and
progression and whether perturbation of innate lymphocytes can
lead to new treatments for human diseases. Finally, the presence of
NH cells in FALC localized in adipose tissue suggests that NH cells
have regulatory functions in the homeostasis of adipose tissues,
which will be an important subject for future studies.
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